Navigation Links
Molecular glue with new effect
Date:1/31/2008

This release is also available in German.

Ten years ago, researchers at the IMP - a basic research institute in Vienna - discovered a fundamental and amazingly plausible mechanism of cell division. They identified a protein complex, which, as a ring-shaped molecule, slides over the doubled chromosomes and holds precisely these together until the time they again separate. Because of its function as molecular glue, the protein complex was given the name cohesin.

In the working group of Jan-Michael Peters, Senior Scientist at the IMP, the molecule was continually monitored over the last ten years. Now Peters and his colleague, Kerstin Wendt, in cooperation with Katsuhiko Shirahige from the Tokyo Institute of Technology, were able to find evidence of another, also essential function of cohesin. As the researchers report in the online issue of the journal Nature, the molecule acts as a regulator of gene expression, and therefore plays an important role in the reading of genes. The molecule fulfills this function entirely independently of its thus far known activity.

Various inhibiting and promoting elements within the genome affect whether genes can be read in a particular situation and how intensively this process proceeds. Promoters initiate the reading process, whereas enhancers strengthen it, and silencers suppress it. The combination of these factors must be very finely tuned. The areas that are each influenced by the regulators are separated from each other by so-called insulators. It has now been ascertained at the IMP for the first time ever that cohesin is necessary for the function of such insulators.

This discovery not only enriches basic research by contributing to further fundamental knowledge. It should also be of medical interest: a number of rare but serious disorders can be traced back to mutations in cohesin. If the regulation of gene expression proceeds abnormally, developmental disorders are the result. The range of symptoms extends from subtle and hard-to-diagnose changes to massive, physical and cognitive impairments. One of the more well-known disorders of this kind is called Cornelia de Lange Syndrome. Affected persons suffer from numerous anomalies and malformations. A causative treatment is not available.

We cannot cure the disease, but we now know the molecular mechanisms that cause it. This helps us to better understand the disorder and its symptoms. Moreover, we expect that our findings will stimulate new exciting research, stated Jan-Michael Peters.

A valuable resource for this has already been created by the researchers in the course of their work: they have systematically searched the entire human genome for cohesin binding sites that is, the areas where cohesin is effective. Thus, the first genome-wide cohesin map in a mammalian species was developed. The database is open to the entire scientific community.


'/>"/>

Contact: Heidemarie Hurtl
hurtl@imp.ac.at
43-179-730-3625
Research Institute of Molecular Pathology
Source:Eurekalert

Related medicine news :

1. Story ideas from Molecular and Cellular Proteomics
2. Findings point to molecular Achilles heel for half of breast cancer tumors
3. The Journal of Biomolecular Screening garners Association TRENDS Bronze Award
4. Molecular pathway appears crucial in development of pulmonary fibrosis
5. New book presents comprehensive survey of research into the molecular basis of aging
6. Childrens Hospital researchers identify molecular switch that could save very young lives
7. In the Forefront of Research into Protein Folding and Macromolecular Complex Assembly
8. Cepheid and Broadlane Sign Group Purchasing Contract for GeneXpert(R) Systems and Xpert(TM) Molecular Diagnostic Tests, Including Xpert MRSA
9. A molecular map for aging in mice
10. Amsterdam Molecular Therapeutics Initiates Program for Late Stage Liver Cirrhosis and Reports Strong Progress in AMT-011 With Trial Fully Recruited and European and US Submission On Track for First Half of 2008
11. 3M, Gen-Probe to Discontinue Molecular Food Testing Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2017)... ... July 23, 2017 , ... A 20-year-long study ... Louis, and led by the Minneapolis Veterans Administration Health Care System overwhelmingly supports growing ... disease offers very few benefits. , In the cases involved with this study, ...
(Date:7/23/2017)... ... July 23, 2017 , ... Technology ... safety and patient-provider relationships. New tools are helping patients become more actively involved ... Annual Health Care’s Most Wired® survey, released today by the American Hospital Association’s ...
(Date:7/23/2017)... ... July 23, 2017 , ... Viora Ltd., a ... US Patent No. 9,038,640 by the United States Patent and Trademark Office. The ... combination of Switching, Vacuum, and Cooling mechanisms to further increase the efficacy and ...
(Date:7/21/2017)... , ... July 21, 2017 , ... "As a doctor ... lot of pleural catheters available on the market," said an inventor from Center Valley, ... and safety for the patient." , He developed the patent-pending PLEURAL SAFE-t-STAT CATHETER KIT ...
(Date:7/21/2017)... ... July 21, 2017 , ... Roderick Crabbe Insurance, ... to families and business owners in northern Florida, is joining the First Coast ... to area adults with developmental challenges. , The First Coast YMCA offers assistance ...
Breaking Medicine News(10 mins):
(Date:7/5/2017)... , July 5, 2017   BioLife Solutions ... developer, manufacturer and marketer of proprietary clinical grade cell ... freeze media ("BioLife"), today announced that it has ... debt holder and largest shareholder, to modify its existing ... Pursuant to the modification, WAVI agreed to exchange its ...
(Date:6/30/2017)... 30, 2017 In vitro diagnostics market firm ... May, at least ten diagnostic companies have successfully completed ... offerings and a loan facility.  The size of these ... million.  Kalorama Information provides a monthly IVD Market ... Knowledge Center. ...
(Date:6/30/2017)... POINT, N.C. , June 29, 2017  Axium Pharmaceuticals Inc. ... for developing improved novel formulations and alternative dosage forms of ... ... delivery is based on our waterless self-nano emulsifying formula, which ... contact with saliva. We believe the spray will provide fast ...
Breaking Medicine Technology: